loader
Please Wait
Applying Filters...

Quotient Sciences Quotient Sciences

X

List of All Manufacturers & Suppliers for 202557 Licensing, EU CTD Dossiers, Marketing Authorizations, Finished Dosage Formulations listed on PharmaCompass.com

Client Virtual Booth
Menu
Filters Filter
Cross PopUp
FILTER :

filter

01 BUSPIRONE HYDROCHLORIDE (5)

02 Buspirone (1)

filter

01 ACCORD HLTHCARE (5)

02 Orion Corporation (1)

filter

01 TABLET (1)

02 TABLET;ORAL (5)

filter

01 10MG (1)

02 15MG (1)

03 30MG (1)

04 5MG (2)

05 7.5MG (1)

filter

01 Canada (1)

02 USA (5)

URL Supplier Web Content
TABLET
5MG
Canada
202557
Generic
Fermion Orion Company Banner

ICRI Spring Convention

Not Confirmed

envelop Contact Supplier
URL Supplier Web Content
TABLET;ORAL
7.5MG
BUSPIRONE HYDROCHLORID...
USA
202557
2014-12-30
RX
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
TABLET;ORAL
30MG
BUSPIRONE HYDROCHLORID...
USA
202557
2014-12-30
RX
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
TABLET;ORAL
10MG
BUSPIRONE HYDROCHLORID...
USA
202557
2014-12-30
RX
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
TABLET;ORAL
5MG
BUSPIRONE HYDROCHLORID...
USA
202557
2014-12-30
RX
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
TABLET;ORAL
15MG
BUSPIRONE HYDROCHLORID...
USA
202557
2014-12-30
RX
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Looking for CTD TGA MCC DOSSIER APPLICATION 202557

Looking for CTD TGA MCC DOSSIER APPLICATION 202557 6

19

Orion Corporation, based in Finland, is a pharmaceutical company that stands out with its certifications from FDA.

One of their notable products is Buspirone, with a corresponding application number 202557 and regulatory information .

proudly manufactured in the

Orion Corporation's TABLET, medication with 5MG of Buspirone.

18

Accord healthcare, based in United Kingdom, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

One of their notable products is BUSPIRONE HYDROCHLORIDE, with a corresponding application number 202557 and regulatory information .

proudly manufactured in the

approval since 2014-12-30

Accord healthcare's BUSPIRONE HYDROCHLORIDE TABLET;ORAL, medication with 7.5MG of BUSPIRONE HYDROCHLORIDE.

17

Accord healthcare, based in United Kingdom, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

One of their notable products is BUSPIRONE HYDROCHLORIDE, with a corresponding application number 202557 and regulatory information .

proudly manufactured in the

approval since 2014-12-30

Accord healthcare's BUSPIRONE HYDROCHLORIDE TABLET;ORAL, medication with 30MG of BUSPIRONE HYDROCHLORIDE.

16

Accord healthcare, based in United Kingdom, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

One of their notable products is BUSPIRONE HYDROCHLORIDE, with a corresponding application number 202557 and regulatory information .

proudly manufactured in the

approval since 2014-12-30

Accord healthcare's BUSPIRONE HYDROCHLORIDE TABLET;ORAL, medication with 10MG of BUSPIRONE HYDROCHLORIDE.

15

Accord healthcare, based in United Kingdom, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

One of their notable products is BUSPIRONE HYDROCHLORIDE, with a corresponding application number 202557 and regulatory information .

proudly manufactured in the

approval since 2014-12-30

Accord healthcare's BUSPIRONE HYDROCHLORIDE TABLET;ORAL, medication with 5MG of BUSPIRONE HYDROCHLORIDE.

14

Accord healthcare, based in United Kingdom, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

One of their notable products is BUSPIRONE HYDROCHLORIDE, with a corresponding application number 202557 and regulatory information .

proudly manufactured in the

approval since 2014-12-30

Accord healthcare's BUSPIRONE HYDROCHLORIDE TABLET;ORAL, medication with 15MG of BUSPIRONE HYDROCHLORIDE.

Post Enquiry
POST ENQUIRY